Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
NEOG — Neogen Corporation
NASDAQ
FULL STOCK PAGE →

NEOG (Neogen Corporation) Q4 2026 Earnings Call Summary

JUL 30, 2026 2 MIN READ
REVENUE
$225.3M +6.7%
NET MARGIN
-5.0% +3.0 PTS
EPS
-$0.05 +37.5%
FREE CASH FLOW
-$9.5M -185.5%

1Key Financial Results and Metrics

Q4 Revenue: $225.3 million, a 4.3% increase on a core basis, marking the highest growth rate of the fiscal year.

Food Safety Revenue: $166.8 million, with core growth of 5.8%, driven by strong performance in indicator testing and culture media products.

Animal Safety Revenue: Grew 0.5% year-over-year, with a 7% sequential increase.

Gross Margin: 47.8%, with an adjusted gross margin of 49.7%, up 330 basis points year-over-year.

Adjusted EBITDA: $45.4 million, representing a margin of 20.2%, up 12% year-over-year.

Cash Flow: Over $30 million in cash flow from operations, with free cash flow exceeding $26 million.

Debt: Approximately $794 million in gross debt, with a cash balance of $185.5 million.

2Strategic Updates and Business Highlights

Core Growth: Notable recovery in both Food Safety and Animal Safety segments, with Food Safety achieving its highest growth since 2023.

Strategic Initiatives: Focus on commercial prowess, high-impact innovation, and operational efficiency.

Commercial Strategy: Transitioning to a solutions-based sales model and enhancing customer engagement through strategic account management.

Innovation Investment: R&D spending to increase by 50%, targeting a long-term goal of 5% of revenue.

Petrifilm Manufacturing Transition: On track for a multi-quarter transition starting November 2026, with the first SKU validation expected in August.

Operational Improvements: Significant reductions in inventory levels and improved on-time delivery metrics.

3Forward Guidance and Outlook

Fiscal Year 2027 Guidance: Expected revenue of $880 million to $885 million, with adjusted EBITDA of $180 million to $182 million, implying core growth of approximately 3%.

Q1 FY27 Guidance: Revenue projected at $207 million to $209 million, with adjusted EBITDA around $37 million.

Long-term Goals: Aiming for approximately 30% adjusted EBITDA margins through disciplined cost management and strategic investments.

4Challenges and Points of Concern

Macroeconomic Headwinds: Customers facing inflationary pressures due to geopolitical factors, which may temper growth despite positive industry trends.

Currency Impact: Anticipated negative 1% impact from currency fluctuations in FY27.

Competitive Landscape: While Neogen aims to lead, there is acknowledgment of needing to catch up in certain areas, particularly in e-commerce capabilities.

Investment Impact on Margins: Increased investments in R&D and operational initiatives may pressure margins in the short term.

5Notable Q&A Insights

EBITDA Guidance Clarification: Concerns were raised regarding the EBITDA guidance being below expectations. Management explained that additional investments would limit margin expansion in FY27.

Core Growth Split: Management did not provide specific growth rates for Food Safety versus Animal Safety but indicated that Food Safety is expected to grow faster.

Strategic Focus: Emphasis on transitioning to a solutions-based approach and engaging with strategic accounts at higher organizational levels to drive growth.

Innovation Timeline: Acknowledgment that the innovation cycle requires early investment to realize future product launches, with a focus on addressing customer needs through differentiated technologies. Overall, Neogen is positioned for growth with a focus on innovation and operational efficiency, despite facing macroeconomic challenges and competitive pressures.

SOURCE: Q4 2026 EARNINGS CALL TRANSCRIPT